RAAP: Alternative Funding Programs Put Rare Patients in Jeopardy

No Rare Disease Patient Should be Required to Use Non-FDA Approved Products

WASHINGTON, Jan. 7, 2026 /PRNewswire/ -- Alternative Funding Programs (AFPs) are shorthand for providing access to illegally procured specialty care and rare therapies. These programs force beneficiaries to jump through administrative and funding hoops to access therapies, and when these are exhausted the programs utilize importation schemes that require patients to use products sourced from countries without FDA approved labels, US warnings and patient information.